1 BTC
=
- USD
iShares U.S. Medical Devices ETF
As of June 25, 2026 at 08:35 UTC
Chart
About iShares U.S. Medical Devices ETF
No description available.
IHI in Bitcoin terms
iShares U.S. Medical Devices ETF is available in Roxom Terminal as an ETF page for investors who want to evaluate global market exposure without leaving a Bitcoin-denominated workflow.
- ETF pages expand Roxom's searchable global-market surface beyond single companies.
- BTC-denominated charting makes the ETF comparable to Bitcoin and other assets in the terminal.
- Related market hubs help users move from a specific ETF to broader BTC-priced markets.
Market Statistics
Trading Metrics
How to Buy IHI
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy IHI
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesBecton, Dickinson and Company received FDA 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, with market launch expected in early 2026. The advanced system features high and low vacuum strengths, 360-degree sampling ability, and multiple probe options. However, analysts expect slightly lower earnings and revenue compared to the prior year quarter, and the stock is considered overvalued despite a consensus Buy rating.
Boston Scientific agreed to acquire thrombectomy specialist Penumbra for $14.5 billion ($374 per share) in a cash-and-stock deal. Penumbra shareholders will receive approximately 73% cash and 27% equity. The acquisition allows Boston Scientific to enter fast-growing vascular segments. Penumbra reported strong preliminary Q4 2025 results with 21-24% revenue growth. Boston Scientific expects 6-8 cents per share dilution in year one, trending toward neutral to accretive thereafter. The deal is expected to close in 2026.
The healthcare sector has faced several headwinds in 2025, leading to lower earnings growth expectations. However, the sector is still expected to be one of the strongest performers in the S&P 500 this year, and some individual stocks and ETFs have shown resilience.
President Trump signed an executive order aimed at reducing prescription drug prices in the U.S. by tying them to the lowest prices paid in other countries. However, legal experts have raised concerns about the legality of the order, and it may face similar challenges as a previous attempt in 2020.
